Asp263 missense variants perturb the active site of human phosphoglucomutase 1
- PMID: 28117557
- PMCID: PMC5802412
- DOI: 10.1111/febs.14025
Asp263 missense variants perturb the active site of human phosphoglucomutase 1
Abstract
The enzyme phosphoglucomutase 1 (PGM1) plays a central role in glucose homeostasis. Clinical studies have identified mutations in human PGM1 as the cause of PGM1 deficiency, an inherited metabolic disease. One residue, Asp263, has two known variants associated with disease: D263G and D263Y. Biochemical studies have shown that these mutants are soluble and well folded, but have significant catalytic impairment. To better understand this catalytic defect, we determined crystal structures of these two missense variants, both of which reveal a similar and indirect structural change due to the loss of a conserved salt bridge between Asp263 and Arg293. The arginine reorients into the active site, making interactions with residues responsible for substrate binding. Biochemical studies also show that the catalytic phosphoserine of the missense variants is more stable to hydrolysis relative to wild-type enzyme. The structural perturbation resulting from mutation of this single amino acid reveals the molecular mechanism underlying PGM1 deficiency in these missense variants.
Database: Structural data are available in the PDB under the accession numbers 5JN5 and 5TR2.
Keywords: X-ray crystallography; inherited disease; missense variants; phosphoglucomutase; phosphoryl transfer.
© 2017 Federation of European Biochemical Societies.
Figures
Similar articles
-
Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.Acta Crystallogr F Struct Biol Commun. 2022 May 1;78(Pt 5):200-209. doi: 10.1107/S2053230X22004174. Epub 2022 Apr 25. Acta Crystallogr F Struct Biol Commun. 2022. PMID: 35506765 Free PMC article.
-
A missense variant remote from the active site impairs stability of human phosphoglucomutase 1.J Inherit Metab Dis. 2020 Jul;43(4):861-870. doi: 10.1002/jimd.12222. Epub 2020 Feb 18. J Inherit Metab Dis. 2020. PMID: 32057119
-
Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency.J Biol Chem. 2014 Nov 14;289(46):32010-32019. doi: 10.1074/jbc.M114.597914. Epub 2014 Oct 6. J Biol Chem. 2014. PMID: 25288802 Free PMC article.
-
Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.J Inherit Metab Dis. 2015 Mar;38(2):243-56. doi: 10.1007/s10545-014-9757-9. Epub 2014 Aug 29. J Inherit Metab Dis. 2015. PMID: 25168163 Review.
-
Enzyme dysfunction at atomic resolution: Disease-associated variants of human phosphoglucomutase-1.Biochimie. 2021 Apr;183:44-48. doi: 10.1016/j.biochi.2020.08.017. Epub 2020 Sep 6. Biochimie. 2021. PMID: 32898648 Review.
Cited by
-
Effects of the T337M and G391V disease-related variants on human phosphoglucomutase 1: structural disruptions large and small.Acta Crystallogr F Struct Biol Commun. 2022 May 1;78(Pt 5):200-209. doi: 10.1107/S2053230X22004174. Epub 2022 Apr 25. Acta Crystallogr F Struct Biol Commun. 2022. PMID: 35506765 Free PMC article.
-
Sequence-structure relationships, expression profiles, and disease-associated mutations in the paralogs of phosphoglucomutase 1.PLoS One. 2017 Aug 24;12(8):e0183563. doi: 10.1371/journal.pone.0183563. eCollection 2017. PLoS One. 2017. PMID: 28837627 Free PMC article.
-
Heterozygous PGM3 Variants Are Associated With Idiopathic Focal Epilepsy With Incomplete Penetrance.Front Genet. 2020 Oct 15;11:559080. doi: 10.3389/fgene.2020.559080. eCollection 2020. Front Genet. 2020. PMID: 33193641 Free PMC article.
-
Structural and dynamical description of the enzymatic reaction of a phosphohexomutase.Struct Dyn. 2019 Apr 1;6(2):024703. doi: 10.1063/1.5092803. eCollection 2019 Mar. Struct Dyn. 2019. PMID: 31041362 Free PMC article.
-
Mechanistic Insights on Human Phosphoglucomutase Revealed by Transition Path Sampling and Molecular Dynamics Calculations.Chemistry. 2018 Feb 6;24(8):1978-1987. doi: 10.1002/chem.201705090. Epub 2018 Jan 4. Chemistry. 2018. PMID: 29131453 Free PMC article.
References
-
- Timal S, Hoischen A, Lehle L, Adamowicz M, Huijben K, Sykut-Cegielska J, Paprocka J, Jamroz E, van Spronsen FJ, Körner C, Gilissen C, Rodenburg RJ, Eidhof I, Van den Heuvel L, Thiel C, Wevers RA, Morava E, Veltman J, Lefeber DJ. Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum. Mol. Genet. 2012;21:4151–4161. - PubMed
-
- Stojkovic T, Vissing J, Petit F, Piraud M, Orngreen MC, Andersen G, Claeys KG, Wary C, Hogrel J-Y, Laforêt P. Muscle Glycogenosis Due to Phosphoglucomutase 1 Deficiency. N. Engl. J. Med. 2009;361:425–427. - PubMed
-
- Pérez B, Medrano C, Ecay MJ, Ruiz-Sala P, Martínez-Pardo M, Ugarte M, Pérez-Cerdá C. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J. Inherit. Metab. Dis. 2012;36:535–542. - PubMed
-
- Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld M-E, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Laforêt P, Petit F, Aumaître O, Czarnowska E, Piraud M, Podskarbi T, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C, Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T. Multiple Phenotypes in Phosphoglucomutase 1 Deficiency. N. Engl. J. Med. 2014;370:533–542. - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
